Frontiers in Neurology | Multiple Sclerosis and Neuroimmunology

Original Research

Published on 04 Dec 2025

Differential diagnoses of MS in clinical practice: incidence and methods for differential diagnosis

in Multiple Sclerosis and Neuroimmunology

Tim Johannes Steinberg
Lucie Mayer
David Freudenstein
Karolina Müller
Klemens Angstwurm
Ralf A. Linker
De-Hyung Lee

Frontiers in Neurology

doi 10.3389/fneur.2025.1695071

1,049 views

Systematic Review

Published on 02 Dec 2025

Brain atrophy in NMOSD and MOGAD: a meta-analysis of volumetric and DTI biomarkers

in Multiple Sclerosis and Neuroimmunology

Ariel Rechtman
Omri Zveik
Adi Vaknin-Dembinsky

Frontiers in Neurology

doi 10.3389/fneur.2025.1703283

1,731 views

Review

Published on 02 Dec 2025

Complement activation in immunological neurological disorders: mechanisms and therapeutic strategies

in Multiple Sclerosis and Neuroimmunology

Jin Y. Chen
Nirav Sanghani
Kaitlyn Palmer
Yuebing Li
Feng Lin
Justin R. Abbatemarco

Frontiers in Neurology

doi 10.3389/fneur.2025.1695461

2,414 views

Original Research

Published on 27 Nov 2025

Correlation between fatigue and quality of life among patients with neuromyelitis optica in West China

in Multiple Sclerosis and Neuroimmunology

Xiaohui Miao
Qi Liu

Frontiers in Neurology

doi 10.3389/fneur.2025.1683353

954 views

Original Research

Published on 12 Nov 2025

Effect of hyperbaric oxygen therapy on peripheral blood inflammatory markers in patients with neuromyelitis optica spectrum disorder: a retrospective cohort study

in Multiple Sclerosis and Neuroimmunology

Liya Pan
Yanming Mo
Yulan Wei
Shisheng Luo
Yuan Wu

Frontiers in Neurology

doi 10.3389/fneur.2025.1670455

2,241 views

Clinical Trial

Published on 06 Nov 2025

Does C1 esterase inhibitor play a role in post COVID-19 neurological symptoms? A randomized, double-blind, placebo-controlled, crossover, proof-of-concept study

in Multiple Sclerosis and Neuroimmunology

Isaac Melamed
Caley Buckley
Mary Ellen Bayko
Joe Lynn Williams
Noga Or-Geva

Frontiers in Neurology

doi 10.3389/fneur.2025.1523814

1,616 views

Original Research

Published on 06 Nov 2025

Familial prevalence of psoriasis in patients with multiple sclerosis – results from an Australian survey

in Multiple Sclerosis and Neuroimmunology

Varitsara Mangkorntongsakul
Ariadna Fontes-Villalba
Chun-Ting Justin Kwong
Olivia Charlton
Helen Marie McGuire
Turlough Montague
Kevin Phan
Venkatesha Venkatesha
Geoffrey Herkes
Saxon Smith

Frontiers in Neurology

doi 10.3389/fneur.2025.1663031

1,547 views

Original Research

Published on 05 Nov 2025

Effects of eculizumab and rituximab on visual function, motor function and social quality in patients with NMOSD: a comparative study

in Multiple Sclerosis and Neuroimmunology

Yihan Liu
Li Meng
Jiyuan Li
Xiao Wang
Xiaoman Zhang
Xiangzeng Kong
Yongzhi Zhang

Frontiers in Neurology

doi 10.3389/fneur.2025.1698950

2,122 views

Original Research

Published on 30 Oct 2025

Validating wearable step counts in multiple sclerosis research: a replication study

in Multiple Sclerosis and Neuroimmunology

Myla D. Goldman
Shanshan Chen
Bhavana Kunisetty
Jeffrey M. Gelfand
Bruce A. C. Cree
Valerie J. Block

Frontiers in Neurology

doi 10.3389/fneur.2025.1709389

1,139 views

Original Research

Published on 29 Oct 2025

A multicenter, prospective cohort study on the anti-SARS-CoV-2 vaccination response in patients with multiple sclerosis in Germany

in Multiple Sclerosis and Neuroimmunology

Achim Berthele
Clemens Gödel
Boris-Alexander Kallmann
Markus Kowarik
Klaus Lehmann-Horn
Martin Marziniak
Sebastian Rauer
Veit Rothhammer
Florian Then Bergh
Mathias Wahl

Frontiers in Neurology

doi 10.3389/fneur.2025.1674742

1,481 views

Original Research

Published on 27 Oct 2025

Factors influencing health behavior changes in people with early multiple sclerosis: process evaluation of the multicenter randomized controlled POWER@MS1 trial

in Multiple Sclerosis and Neuroimmunology

Barbara von Glasenapp
Nicole Krause
Carlotta Derad
Karin Riemann-Lorenz
Björn Meyer
Markus van de Loo
Herbert Temmes
Stefan Gold
Christoph Heesen

Frontiers in Neurology

doi 10.3389/fneur.2025.1635872

1,835 views

Systematic Review

Published on 23 Oct 2025

Effectiveness of respiratory muscle training in adults with multiple sclerosis: a systematic review and meta-analysis

in Multiple Sclerosis and Neuroimmunology

Yuping Xiang
Oufeng Tang
Ling Zeng

Frontiers in Neurology

doi 10.3389/fneur.2025.1665651

1,808 views

Original Research

Published on 23 Oct 2025

The neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with neuromyelitis optica spectrum disorders and multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Qingli Sun
Xinran Ma
Linjing Zhang
Danyang Tian

Frontiers in Neurology

doi 10.3389/fneur.2025.1598885

1,732 views
1 citation

Original Research

Published on 17 Oct 2025

Comparison between primary and secondary central nervous system vasculitis in terms of clinical, biochemical, radiological, histopathological features, and outcomes: a single-center retrospective cohort study

in Multiple Sclerosis and Neuroimmunology

Pasquale Scoppettuolo
Lucie Pothen
Aline van Maanen
Valeria Onofrj
Selda Aydin
Olivier Gheysens
Renaud Lhommel
André Peeters
Vincent van Pesch
Halil Yildiz

Frontiers in Neurology

doi 10.3389/fneur.2025.1602427

2,982 views
1 citation

Opinion

Published on 15 Oct 2025

Dyadic sleep in people with multiple sclerosis and their partners: current research and future directions

in Multiple Sclerosis and Neuroimmunology

Anna Zanotto
Catherine F. Siengsukon

Frontiers in Neurology

doi 10.3389/fneur.2025.1682411

1,264 views

Review

Published on 13 Oct 2025

Treatment and prognosis of failure of first-line immunotherapy or recurrent autoimmune encephalitis patients with ofatumumab—a fully human anti-CD20 mAb

in Multiple Sclerosis and Neuroimmunology

Yajing Liu
Yanbo Zhang
Zhijiao Song
Shuanghao Feng
Tongxin Cao
Hui Bu

Frontiers in Neurology

doi 10.3389/fneur.2025.1671481

1,654 views

Systematic Review

Published on 10 Oct 2025

Effects of non-invasive brain stimulation on balance control in patients with multiple sclerosis: a systematic review and meta-analysis

in Multiple Sclerosis and Neuroimmunology

Longtao Zhang
Yanxiao Sun
Zhihao Diao
Yifan Jiang
Yufei Hu
Yuxia Ma

Frontiers in Neurology

doi 10.3389/fneur.2025.1696343

2,478 views

Original Research

Published on 09 Oct 2025

Predictors of therapy switching to high-efficacy disease-modifying therapies in patients with multiple sclerosis: a single center, retrospective, observational study

in Multiple Sclerosis and Neuroimmunology

Gytis Makarevičius
Rasa Kizlaitienė
Gintaras Kaubrys
Nataša Giedraitienė

Frontiers in Neurology

doi 10.3389/fneur.2025.1635618

2,071 views
2 citations

Systematic Review

Published on 07 Oct 2025

Pharmacological treatment options for cognitive dysfunction induced by multiple sclerosis: a network meta-analysis

in Multiple Sclerosis and Neuroimmunology

Zhuyuan Fan
Dan Liu
Guangwei Zhang
Xinlin Guo

Frontiers in Neurology

doi 10.3389/fneur.2025.1649429

2,905 views

Original Research

Published on 02 Oct 2025

The frequency of psoriasis in Australian multiple sclerosis patients

in Multiple Sclerosis and Neuroimmunology

Varitsara Mangkorntongsakul
Ariadna Fontes-Villalba
Turlough Montague
Olivia Charlton
Chun-Ting Justin Kwong
Helen Marie McGuire
Venkatesha Venkatesha
Geoffrey Herkes
Saxon Smith
John Parratt

Frontiers in Neurology

doi 10.3389/fneur.2025.1663015

2,115 views
1 citation

Editorial

Published on 30 Sep 2025

Editorial: Women in multiple sclerosis and neuroimmunology: from bench to bedside

in Multiple Sclerosis and Neuroimmunology

Jessy J. Alexander
Krista D. DiSano
Liliana Patrucco
Mireya Fernandez-Fournier

Frontiers in Neurology

doi 10.3389/fneur.2025.1677618

1,726 views

Original Research

Published on 30 Sep 2025

Evaluating the impact of task-sequencing on cognitive and motor performance in MS: PASAT and 3-minute walk test order effects

in Multiple Sclerosis and Neuroimmunology

Valentin Siegert
Laura J. Köhler
Lucas Schreff
Daniel Hamacher
Patrick Oschmann
Veit Rothhammer
Philipp M. Keune
Roy Müller

Frontiers in Neurology

doi 10.3389/fneur.2025.1654656

1,763 views

Policy and Practice Reviews

Published on 29 Sep 2025

Glial fibrillary acidic protein autoimmunity in reversible splenial lesion syndrome: diagnostic and therapeutic implications

in Multiple Sclerosis and Neuroimmunology

Lingling Lin
Xiang Li
Chao Quan
Jingzi Zhangbao
Hongmei Tan
Yi Wang
Siyuan Xu
Zhihao Dai

Frontiers in Neurology

doi 10.3389/fneur.2025.1650256

2,168 views

Original Research

Published on 29 Sep 2025

From demyelination to neurodegeneration in multiple sclerosis: reassessing the role of visual evoked potential P100-N145 amplitudes: a missing piece of the puzzle?

in Multiple Sclerosis and Neuroimmunology

Nurhan Kaya Tutar
Nilufer Kale

Frontiers in Neurology

doi 10.3389/fneur.2025.1649998

1,915 views

1,192 articles

articles

Differential diagnoses of MS in clinical practice: incidence and methods for differential diagnosis

Brain atrophy in NMOSD and MOGAD: a meta-analysis of volumetric and DTI biomarkers

Complement activation in immunological neurological disorders: mechanisms and therapeutic strategies

Correlation between fatigue and quality of life among patients with neuromyelitis optica in West China

Effect of hyperbaric oxygen therapy on peripheral blood inflammatory markers in patients with neuromyelitis optica spectrum disorder: a retrospective cohort study

Does C1 esterase inhibitor play a role in post COVID-19 neurological symptoms? A randomized, double-blind, placebo-controlled, crossover, proof-of-concept study

Familial prevalence of psoriasis in patients with multiple sclerosis – results from an Australian survey

Effects of eculizumab and rituximab on visual function, motor function and social quality in patients with NMOSD: a comparative study

Validating wearable step counts in multiple sclerosis research: a replication study

A multicenter, prospective cohort study on the anti-SARS-CoV-2 vaccination response in patients with multiple sclerosis in Germany

Factors influencing health behavior changes in people with early multiple sclerosis: process evaluation of the multicenter randomized controlled POWER@MS1 trial

Effectiveness of respiratory muscle training in adults with multiple sclerosis: a systematic review and meta-analysis

The neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with neuromyelitis optica spectrum disorders and multiple sclerosis

Comparison between primary and secondary central nervous system vasculitis in terms of clinical, biochemical, radiological, histopathological features, and outcomes: a single-center retrospective cohort study

Dyadic sleep in people with multiple sclerosis and their partners: current research and future directions

Treatment and prognosis of failure of first-line immunotherapy or recurrent autoimmune encephalitis patients with ofatumumab—a fully human anti-CD20 mAb

Effects of non-invasive brain stimulation on balance control in patients with multiple sclerosis: a systematic review and meta-analysis

Predictors of therapy switching to high-efficacy disease-modifying therapies in patients with multiple sclerosis: a single center, retrospective, observational study

Pharmacological treatment options for cognitive dysfunction induced by multiple sclerosis: a network meta-analysis

The frequency of psoriasis in Australian multiple sclerosis patients

Editorial: Women in multiple sclerosis and neuroimmunology: from bench to bedside

Evaluating the impact of task-sequencing on cognitive and motor performance in MS: PASAT and 3-minute walk test order effects

Glial fibrillary acidic protein autoimmunity in reversible splenial lesion syndrome: diagnostic and therapeutic implications

From demyelination to neurodegeneration in multiple sclerosis: reassessing the role of visual evoked potential P100-N145 amplitudes: a missing piece of the puzzle?